ZBIO
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO
Delisted
ZBIO was delisted on the 27th of March, 2020.
5 hedge funds and large institutions have $677K invested in ProShares UltraPro Short NASDAQ Biotechnology in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
-3
Holders Change %
-37.5%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
3
Closed
4
Calls
$575K
Puts
$168K
Net Calls
+$407K
Net Calls Change
+$442K
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$334K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $334K | +$334K | +14,722 | New |
|
|
VF
2
Virtu Financial
New York
| $304K | -$415K | -18,289 | -58% |
|
3
UBS Group
Zurich,
Switzerland
| $27K | -$18.3K | -787 | -40% |
|
|
CG
4
Cutler Group
San Francisco,
California
| $9K | – | – | – |
|
5
Morgan Stanley
New York
| $3K | -$3.8K | -213 | -56% |
|
6
Jane Street
New York
| – | -$108K | -5,201 | Closed |
|
|
BP
7
Ballentine Partners
Waltham,
Massachusetts
| – | -$104K | -5,000 | Closed |
|
|
GHAM
8
Gilman Hill Asset Management
New Canaan,
Connecticut
| – | -$104K | -5,000 | Closed |
|